| Year |
Citation |
Score |
| 2023 |
Fan AC, Nakauchi Y, Bai L, Azizi A, Nuno KA, Zhao F, Köhnke T, Karigane D, Cruz-Hernandez D, Reinisch A, Khatri P, Majeti R. RUNX1 loss renders hematopoietic and leukemic cells dependent on interleukin-3 and sensitive to JAK inhibition. The Journal of Clinical Investigation. PMID 37581927 DOI: 10.1172/JCI167053 |
0.75 |
|
| 2023 |
Sconocchia T, Foßelteder J, Köhnke T, Majeti R, Reinisch A. Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments : Jove. PMID 36971438 DOI: 10.3791/64558 |
0.614 |
|
| 2023 |
Foßelteder J, Pabst G, Sconocchia T, Schlacher A, Auinger L, Kashofer K, Beham-Schmid C, Trajanoski S, Waskow C, Schöll W, Sill H, Zebisch A, Wölfler A, Thomas D, Reinisch A. Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia. PMID 36813992 DOI: 10.1038/s41375-023-01848-6 |
0.624 |
|
| 2023 |
Thompson-Peach CAL, Foßelteder J, Reinisch A, Thomas D. Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms. Bio-Protocol. 13: e4592. PMID 36789162 DOI: 10.21769/BioProtoc.4592 |
0.564 |
|
| 2022 |
Thomas D, Wu M, Nakauchi Y, Zheng M, Thompson-Peach CA, Lim K, Landberg N, Köhnke T, Robinson N, Kaur S, Kutyna M, Stafford M, Hiwase D, Reinisch A, Peltz G, et al. Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer Discovery. PMID 36355448 DOI: 10.1158/2159-8290.CD-21-0218 |
0.622 |
|
| 2022 |
Nakauchi Y, Azizi A, Thomas D, Corces MR, Reinisch A, Sharma R, Cruz Hernandez D, Kohnke T, Karigane D, Fan A, Martinez-Krams D, Stafford M, Kaur S, Dutta R, Phan P, et al. The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia. Blood Cancer Discovery. PMID 35532363 DOI: 10.1158/2643-3230.BCD-21-0143 |
0.783 |
|
| 2022 |
Tvorogov D, Thompson-Peach CAL, Foßelteder J, Dottore M, Stomski F, Onnesha SA, Lim K, Moretti PAB, Pitson SM, Ross DM, Reinisch A, Thomas D, Lopez AF. Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody. Embo Reports. e52904. PMID 35156745 DOI: 10.15252/embr.202152904 |
0.509 |
|
| 2021 |
Jensen TI, Mikkelsen NS, Gao Z, Foßelteder J, Pabst G, Axelgaard E, Laustsen A, König S, Reinisch A, Bak RO. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome Research. PMID 34407984 DOI: 10.1101/gr.275607.121 |
0.412 |
|
| 2020 |
Mantri S, Reinisch A, Dejene BT, Lyell DJ, DiGiusto DL, Agarwal-Hashmi R, Majeti R, Weinberg KI, Porteus MH. CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products. Blood Advances. 4: 5357-5361. PMID 33136125 DOI: 10.1182/bloodadvances.2020002891 |
0.61 |
|
| 2020 |
Daga S, Rosenberger A, Kashofer K, Heitzer E, Quehenberger F, Halbwedl I, Graf R, Krisper N, Prietl B, Höfler G, Reinisch A, Zebisch A, Sill H, Wölfler A. Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling. American Journal of Hematology. PMID 32602117 DOI: 10.1002/Ajh.25918 |
0.419 |
|
| 2020 |
Koldobskiy MA, Abante J, Jenkinson G, Pujadas E, Tetens A, Zhao F, Tryggvadottir R, Idrizi A, Reinisch A, Majeti R, Goutsias J, Feinberg AP. A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML. Epigenetics. 1-18. PMID 32114880 DOI: 10.1080/15592294.2020.1734149 |
0.579 |
|
| 2020 |
Pabst G, Lind K, Graf R, Zebisch A, Stölzel F, Döhner K, Heitzer E, Reinisch A, Sill H. TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model. Annals of Hematology. PMID 32002654 DOI: 10.1007/S00277-020-03920-Y |
0.422 |
|
| 2019 |
Daga S, Rosenberger A, Quehenberger F, Krisper N, Prietl B, Reinisch A, Zebisch A, Sill H, Wölfler A. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML. Cancer Medicine. 8: 1771-1778. PMID 30848055 DOI: 10.1002/Cam4.2053 |
0.404 |
|
| 2019 |
Koehnke T, Sharma R, Nakauchi Y, Reinisch A, Majeti R. Induction of Truncating ASXL1 Mutations in Human CD34+ HSPCs Mimics Human ASXL1-Mutated Clonal Hematopoiesis and Progression to Myeloid Malignancies Blood. 134: 820-820. DOI: 10.1182/Blood-2019-130528 |
0.535 |
|
| 2019 |
Fan A, Nuno K, Nakauchi Y, Koehnke T, Kim S, Reinisch A, Cruz-Hernandez D, Majeti R. MODELING THE PATHOGENESIS OF RUNX1 DEFICIENCY IN INHERITED AML PREDISPOSITION SYNDROMES IN PRIMARY CELLS Experimental Hematology. 76: S65. DOI: 10.1016/J.Exphem.2019.06.354 |
0.531 |
|
| 2018 |
Bak RO, Dever DP, Reinisch A, Cruz Hernandez D, Majeti R, Porteus MH. Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. Elife. 7. PMID 30444489 DOI: 10.7554/eLife.43690 |
0.62 |
|
| 2018 |
Chan CKF, Gulati GS, Sinha R, Tompkins JV, Lopez M, Carter AC, Ransom RC, Reinisch A, Wearda T, Murphy M, Brewer RE, Koepke LS, Marecic O, Manjunath A, Seo EY, et al. Identification of the Human Skeletal Stem Cell. Cell. 175: 43-56.e21. PMID 30241615 DOI: 10.1016/J.Cell.2018.07.029 |
0.731 |
|
| 2018 |
Nakauchi Y, Thomas D, Sharma R, Corces MR, Reinisch A, Cruz D, Koehnke T, Karigane D, Fan A, Majeti R. Azacitidine and Ascorbate Inhibit the Competitive Outgrowth of Human TET2 Mutant HSPCs in a Xenograft Model of Pre-Leukemia Blood. 132: 887-887. DOI: 10.1182/Blood-2018-99-113907 |
0.736 |
|
| 2018 |
Fan A, Reinisch A, Majeti R. Cell Autonomous and Non-Autonomous Effects of RUNX1 Deficiency in Inherited AML Predisposition Syndromes Experimental Hematology. 64: S64. DOI: 10.1016/J.Exphem.2018.06.221 |
0.586 |
|
| 2017 |
Karamitros D, Stoilova B, Aboukhalil Z, Hamey F, Reinisch A, Samitsch M, Quek L, Otto G, Repapi E, Doondeea J, Usukhbayar B, Calvo J, Taylor S, Goardon N, Six E, et al. Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells. Nature Immunology. PMID 29167569 DOI: 10.1038/S41590-017-0001-2 |
0.695 |
|
| 2017 |
Bak RO, Dever DP, Reinisch A, Cruz Hernandez D, Majeti R, Porteus MH. Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. Elife. 6. PMID 28956530 DOI: 10.7554/Elife.27873 |
0.688 |
|
| 2017 |
Reinisch A, Hernandez DC, Schallmoser K, Majeti R. Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice. Nature Protocols. 12: 2169-2188. PMID 28933777 DOI: 10.1038/Nprot.2017.088 |
0.686 |
|
| 2017 |
Sinha S, Thomas D, Chan S, Gao Y, Brunen D, Torabi D, Reinisch A, Hernandez D, Chan A, Rankin EB, Bernards R, Majeti R, Dill DL. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data. Nature Communications. 8: 15580. PMID 28561042 DOI: 10.1038/Ncomms15580 |
0.725 |
|
| 2017 |
Sinha S, Thomas D, Chan S, Gao Y, Brunen D, Torabi D, Reinisch A, Bernards R, Majeti R, Dill DL. Abstract A27: Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer primary tumor data Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-A27 |
0.744 |
|
| 2017 |
Stoilova B, Karamitros D, Aboukhalil Z, Reinisch A, Hamey F, Samitsch M, Quek L, Otto G, Repapi E, Doondeea J, Usukhbayar B, Calvo J, Taylor S, Goardon N, Six E, et al. Single cell assays unveil functional and transcriptional heterogeneity of human hemopoietic lympho-myeloid progenitors Experimental Hematology. 53: S50. DOI: 10.1016/J.Exphem.2017.06.074 |
0.658 |
|
| 2016 |
Chao MP, Gentles AJ, Chatterjee S, Lan F, Reinisch A, Corces MR, Xavy S, Shen J, Haag D, Chanda S, Sinha R, Morganti RM, Nishimura T, Ameen M, Wu H, et al. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell Stem Cell. PMID 28089908 DOI: 10.1016/J.Stem.2016.11.018 |
0.787 |
|
| 2016 |
Reinisch A, Majeti R. Sticking It to the Niche: CD98 Mediates Critical Adhesive Signals in AML. Cancer Cell. 30: 662-664. PMID 27846387 DOI: 10.1016/J.Ccell.2016.10.014 |
0.659 |
|
| 2016 |
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, Pavel-Dinu M, Saxena N, Wilkens AB, Mantri S, Uchida N, Hendel A, Narla A, Majeti R, Weinberg KI, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. PMID 27820943 DOI: 10.1038/Nature20134 |
0.67 |
|
| 2016 |
Reinisch A, Thomas D, Corces MR, Zhang X, Gratzinger D, Hong WJ, Schallmoser K, Strunk D, Majeti R. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nature Medicine. PMID 27213817 DOI: 10.1038/Nm.4103 |
0.723 |
|
| 2016 |
Szöke K, Reinisch A, Østrup E, Reinholt FP, Brinchmann JE. Autologous cell sources in therapeutic vasculogenesis: In vitro and in vivo comparison of endothelial colony-forming cells from peripheral blood and endothelial cells isolated from adipose tissue. Cytotherapy. 18: 242-52. PMID 26669908 DOI: 10.1016/J.Jcyt.2015.10.009 |
0.392 |
|
| 2016 |
Chao MP, Andrew G, Susmita C, Reinisch A, Corces MR, Shen J, Rachel M, Singha R, Haag D, Wernig M, Wu J, Majeti R. Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of Subclones Blood. 128: 575-575. DOI: 10.1182/Blood.V128.22.575.575 |
0.569 |
|
| 2016 |
Bak RO, Dever DP, Saxena N, Camarena J, Reinisch A, Wilkens AB, Nicolas CE, Hendel A, Majeti R, Weinberg KI, Porteus MH. 43. CRISPR/Cas9 and rAAV6-Mediated Targeted Integration at the CCR5 Locus in Hematopoietic Stem and Progenitor Cells Molecular Therapy. 24: S19. DOI: 10.1016/S1525-0016(16)32852-0 |
0.677 |
|
| 2016 |
Dever DP, Bak RO, Camarena J, Saxena N, Reinisch A, Nicolas CE, Wilkens AB, Hendel A, Uchida N, Majeti R, Weinberg KI, Porteus MH. 39. FACS-Based Enrichment of a Highly Purified HBB-Targeted Hematopoietic Stem and Progenitor Cell Population Using rAAV6 and CRISPR/Cas9 Molecular Therapy. 24: S17. DOI: 10.1016/S1525-0016(16)32848-9 |
0.689 |
|
| 2016 |
Porteus M, Bak R, Dever D, Hendel A, Reinisch A, Majeti R. Genome editing by homologous recombination of human hematopoietic stem cells Experimental Hematology. 44: S26. DOI: 10.1016/J.Exphem.2016.06.014 |
0.658 |
|
| 2015 |
Ketterl N, Brachtl G, Schuh C, Bieback K, Schallmoser K, Reinisch A, Strunk D. A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance. Stem Cell Research & Therapy. 6: 236. PMID 26620155 DOI: 10.1186/S13287-015-0233-8 |
0.445 |
|
| 2015 |
Mazumdar C, Shen Y, Xavy S, Zhao F, Reinisch A, Li R, Corces MR, Flynn RA, Buenrostro JD, Chan SM, Thomas D, Koenig JL, Hong WJ, Chang HY, Majeti R. Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation. Cell Stem Cell. PMID 26607380 DOI: 10.1182/Blood.V126.23.841.841 |
0.771 |
|
| 2015 |
Reinisch A, Chan SM, Thomas D, Majeti R. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells. Seminars in Hematology. 52: 150-64. PMID 26111462 DOI: 10.1053/J.Seminhematol.2015.03.008 |
0.773 |
|
| 2015 |
Reinisch A, Etchart N, Thomas D, Hofmann NA, Fruehwirth M, Sinha S, Chan CK, Senarath-Yapa K, Seo EY, Wearda T, Hartwig UF, Beham-Schmid C, Trajanoski S, Lin Q, Wagner W, et al. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood. 125: 249-60. PMID 25406351 DOI: 10.1182/Blood-2014-04-572255 |
0.75 |
|
| 2015 |
Sinha S, Thomas D, Yu L, Gentles AJ, Jung N, Corces-Zimmerman MR, Chan SM, Reinisch A, Feinberg AP, Dill DL, Majeti R. Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition. Blood. 125: 316-26. PMID 25398938 DOI: 10.1182/Blood-2014-03-566018 |
0.743 |
|
| 2015 |
Diwoky C, Liebmann D, Neumayer B, Reinisch A, Knoll F, Strunk D, Stollberger R. Positive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFP Nmr in Biomedicine. 28: 79-88. PMID 25379657 DOI: 10.1002/Nbm.3229 |
0.322 |
|
| 2015 |
König J, Weiss G, Rossi D, Wankhammer K, Reinisch A, Kinzer M, Huppertz B, Pfeiffer D, Parolini O, Lang I. Placental mesenchymal stromal cells derived from blood vessels or avascular tissues: what is the better choice to support endothelial cell function? Stem Cells and Development. 24: 115-31. PMID 25244528 DOI: 10.1089/Scd.2014.0115 |
0.435 |
|
| 2014 |
Kinzer M, Hingerl K, König J, Reinisch A, Strunk D, Huppertz B, Lang I. Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo. Placenta. 35: 517-519. PMID 24814611 DOI: 10.1016/J.Placenta.2014.04.004 |
0.447 |
|
| 2014 |
Reinisch A, Gratzinger D, Hong W, Majeti R. A Novel Humanized Bone Marrow Niche Xenotransplantation Model Allows Superior Engraftment of Human Normal and Malignant Hematopoietic Cells and Reveals Myelofibrosis-Initiating Cells in the HSC Compartment Blood. 124: 349-349. DOI: 10.1182/Blood.V124.21.349.349 |
0.551 |
|
| 2014 |
Reinisch A, Majeti R. An in vivo model of primary myelofibrosis using a humanized bone marrow niche reveals disease-initiating cells enriched in the CD34+/CD38-/CD90+ hematopoietic compartment Experimental Hematology. 42: S18. DOI: 10.1016/J.Exphem.2014.07.064 |
0.595 |
|
| 2013 |
Rohban R, Reinisch A, Etchart N, Schallmoser K, Hofmann NA, Szoke K, Brinchmann JE, Bonyadi Rad E, Rohde E, Strunk D. Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling. Plos One. 8: e66909. PMID 23826172 DOI: 10.1371/Journal.Pone.0066909 |
0.438 |
|
| 2012 |
Hofmann NA, Ortner A, Jacamo RO, Reinisch A, Schallmoser K, Rohban R, Etchart N, Fruehwirth M, Beham-Schmid C, Andreeff M, Strunk D. Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo. Plos One. 7: e44468. PMID 22970226 DOI: 10.1371/Journal.Pone.0044468 |
0.431 |
|
| 2012 |
Templin C, Zweigerdt R, Schwanke K, Olmer R, Ghadri JR, Emmert MY, Müller E, Küest SM, Cohrs S, Schibli R, Kronen P, Hilbe M, Reinisch A, Strunk D, Haverich A, et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation. 126: 430-9. PMID 22767659 DOI: 10.1161/Circulationaha.111.087684 |
0.444 |
|
| 2012 |
Hofmann NA, Reinisch A, Strunk D. Endothelial colony-forming progenitor cell isolation and expansion. Methods in Molecular Biology (Clifton, N.J.). 879: 381-7. PMID 22610572 DOI: 10.1007/978-1-61779-815-3_23 |
0.401 |
|
| 2012 |
Chen Y, Jacamo R, Shi YX, Wang RY, Battula VL, Konoplev S, Strunk D, Hofmann NA, Reinisch A, Konopleva M, Andreeff M. Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Blood. 119: 4971-80. PMID 22490334 DOI: 10.1182/Blood-2011-11-389957 |
0.486 |
|
| 2012 |
Vaculik C, Schuster C, Bauer W, Iram N, Pfisterer K, Kramer G, Reinisch A, Strunk D, Elbe-Bürger A. Human dermis harbors distinct mesenchymal stromal cell subsets. The Journal of Investigative Dermatology. 132: 563-74. PMID 22048731 DOI: 10.1038/Jid.2011.355 |
0.511 |
|
| 2012 |
Hofmann NA, Ortner A, Jacamo R, Reinisch A, Schallmoser K, Rohban R, Frühwirth M, Liechtenstein N, Beham-Schmid C, Linkesch W, Andreeff M, Strunk D. A Novel Role for Mesenchymal Stem/Progenitor Cells As Hypoxia Sensors During Initiation of Neo-Vasculogenesis in Vivo Blood. 120: 613-613. DOI: 10.1182/Blood.V120.21.613.613 |
0.397 |
|
| 2012 |
Reinisch A, Etchart N, Hofmann NA, Frühwirth M, Ortner A, Thaler D, Feilhauer B, Hartwig UF, Beham-Schmid C, Trajanosky S, Wagner W, Alves F, Schallmoser K, Andreeff M, Strunk D. Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo. Blood. 120: 2987-2987. DOI: 10.1182/Blood.V120.21.2987.2987 |
0.492 |
|
| 2012 |
Schallmoser K, Hofmann NA, Reinisch A, Ortner A, Url C, Etchart N, Joussen S, Wagner W, Strunk D. Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions Blood. 120: 1916-1916. DOI: 10.1182/Blood.V120.21.1916.1916 |
0.387 |
|
| 2012 |
Andreeff M, Chen Y, Battula VL, Hofmann NA, Reinisch A, Shi YX, Wang RY, Konoplev S, Strunk D, Konopleva M. Abstract 2971: Human extramedullary bone and bone marrow in mice: Firstin vivomodel of a genetically controlled hematopoietic environment - Role of CTGF and HIF1-α Cancer Research. 72: 2971-2971. DOI: 10.1158/1538-7445.Am2012-2971 |
0.482 |
|
| 2011 |
Rohde E, Schallmoser K, Reinisch A, Hofmann NA, Pfeifer T, Fröhlich E, Rechberger G, Lanzer G, Kratky D, Strunk D. Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation. Cytotherapy. 13: 503-12. PMID 21128706 DOI: 10.3109/14653249.2010.536214 |
0.497 |
|
| 2011 |
Hofmann NA, Ortner A, Jacamo RO, Reinisch A, Schallmoser K, Fruewirth M, Diwoky C, Rohban R, Beham-Schmid C, Andreeff M, Strunk D. Neo-Vasculogenesis In Vivo Is Facilitated by Oxygen Sensing Mesenchymal Stem and Pogenitor Cells Blood. 118: 699-699. DOI: 10.1182/Blood.V118.21.699.699 |
0.411 |
|
| 2011 |
Reinisch A, Liechtenstein N, Hofmann NA, Ortner A, Frühwirth M, Schallmoser K, Beham-Schmid C, Strunk D. Dissociation of In Vivo and in Vitro Differentiation Capacity of Human Mesenchymal Stem Cells Is Reflected by a Tissue Specific Epigenetic Memory Blood. 118: 2386-2386. DOI: 10.1182/Blood.V118.21.2386.2386 |
0.484 |
|
| 2011 |
Etchart N, Reinisch A, Ortner A, Frühwirth M, Rohban R, Url C, Schallmoser K, Beham-Schmid C, Strunk D. Platelet-Derived Factors Allow Human Mesenchymal Stem Cells to Spontaneously Undergo Endochondral Bone Differentiation and Provide Bone Marrow Support in a Xenogenic In Vivo Model Blood. 118: 1322-1322. DOI: 10.1182/Blood.V118.21.1322.1322 |
0.446 |
|
| 2010 |
Schallmoser K, Bartmann C, Rohde E, Bork S, Guelly C, Obenauf AC, Reinisch A, Horn P, Ho AD, Strunk D, Wagner W. Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica. 95: 867-74. PMID 20053868 DOI: 10.3324/Haematol.2009.011692 |
0.426 |
|
| 2010 |
Reinisch A, Etchart N, Hofmann NA, Ortner A, Rohde E, Schallmoser K, Beham-Schmid C, Dullin C, Diwoky C, Hofmeister A, Stollberger R, Alves F, Strunk D. Human Vascular Progenitor Cells Can Guide Mesodermal Lineage Choice of Mesenchymal Stem and Progenitor Cells After Co-Transplantation In Vivo. Blood. 116: 939-939. DOI: 10.1182/Blood.V116.21.939.939 |
0.531 |
|
| 2010 |
Schallmoser K, Bartmann C, Rohde E, Bork S, Guelly C, Obenauf AC, Reinisch A, Horn P, Ho AD, Linkesch W, Lanzer G, Wagner W, Strunk D. Replicative Senescence-Associated Gene Expression Changes In Human MSPCs Independent of Genomic Variations Blood. 116: 4775-4775. DOI: 10.1182/Blood.V116.21.4775.4775 |
0.437 |
|
| 2010 |
Rohde E, Schallmoser K, Reinisch A, Hofmann NA, Pfeifer T, Rechberger G, Kratky D, Fröhlich E, Strunk D. Pro–angiogenic Induction of Myeloid Cells for Therapeutic Angiogenesis Can Favor MAPK p38–dependent Foam Cell Formation Blood. 116: 4442-4442. DOI: 10.1182/Blood.V116.21.4442.4442 |
0.5 |
|
| 2010 |
Hofmann NA, Reinisch A, Ortner A, Schallmoser K, Rohde E, Absenger M, Birner-Gruenberger R, Strunk D. Oxygen Sensing of Mesenchymal Stem and Progenitor Cells Facilitates Neo-Vasculogenesis In Vivo Blood. 116: 4313-4313. DOI: 10.1182/Blood.V116.21.4313.4313 |
0.439 |
|
| 2009 |
Schallmoser K, Rohde E, Bartmann C, Obenauf AC, Reinisch A, Strunk D. Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Bio-Medical Materials and Engineering. 19: 271-6. PMID 20042793 DOI: 10.3233/Bme-2009-0591 |
0.466 |
|
| 2009 |
Hofmann NA, Reinisch A, Strunk D. Isolation and large scale expansion of adult human endothelial colony forming progenitor cells. Journal of Visualized Experiments : Jove. PMID 19861942 DOI: 10.3791/1524 |
0.432 |
|
| 2009 |
Reinisch A, Strunk D. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). Journal of Visualized Experiments : Jove. PMID 19816400 DOI: 10.3791/1525 |
0.508 |
|
| 2009 |
Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, Flicker K, Lanzer G, Linkesch W, Speicher MR, Strunk D. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood. 113: 6716-25. PMID 19321860 DOI: 10.1182/Blood-2008-09-181362 |
0.433 |
|
| 2008 |
Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Engineering. Part C, Methods. 14: 185-96. PMID 18620484 DOI: 10.1089/Ten.Tec.2008.0060 |
0.448 |
|
| 2008 |
Frühwirth M, Thaler D, Reinisch A, Schallmoser K, Rohde E, Hofmann NA, Linkesch W, Strunk D. Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System Blood. 112: 2410-2410. DOI: 10.1182/Blood.V112.11.2410.2410 |
0.484 |
|
| 2008 |
Schallmoser K, Rohde E, Reinisch A, Obenauf AC, Bartmann C, Lanzer G, Linkesch W, Strunk D. Genomic Stability and Safety of MSCs after Animal Serum-Free Humanized Clinical Scale Propagation. Blood. 112: 2307-2307. DOI: 10.1182/Blood.V112.11.2307.2307 |
0.438 |
|
| 2008 |
Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, Thaler D, Frühwirth M, Linkesch W, Speicher MR, Strunk D. Making Functional Endothelial Progenitors: Humanized Large-Scale Animal Serum-Free Propagated Adult Blood-Derived Endothelial Colony-Forming Cells Assemble Stable Perfused Vessels in Vivo. Blood. 112: 1882-1882. DOI: 10.1182/Blood.V112.11.1882.1882 |
0.455 |
|
| 2007 |
Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 47: 1436-46. PMID 17655588 DOI: 10.1111/J.1537-2995.2007.01220.X |
0.441 |
|
| 2007 |
Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G, Linkesch W, Strunk D. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regenerative Medicine. 2: 371-82. PMID 17635045 DOI: 10.2217/17460751.2.4.371 |
0.457 |
|
| 2007 |
Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells (Dayton, Ohio). 25: 1746-52. PMID 17395771 DOI: 10.1634/Stemcells.2006-0833 |
0.432 |
|
| 2006 |
Malischnik C, Schallmoser K, Rohde E, Reinisch A, Guelly C, Lanzer G, Linkesch W, Strunk D. Human Platelet-Derived Factors Regulate Mesenchymal Stem Cell Gene Expression. Blood. 108: 4255-4255. DOI: 10.1182/Blood.V108.11.4255.4255 |
0.535 |
|
| 2006 |
Schallmoser K, Malischnik C, Rohde E, Reinisch A, Guelly C, Lanzer G, Linkesch W, Strunk D. Human Mesenchymal Stem Cell Therapy: Platelet Lysate Supports Efficient Preclinical Expansion. Blood. 108: 3649-3649. DOI: 10.1182/Blood.V108.11.3649.3649 |
0.486 |
|
| 2006 |
Rohde E, Malischnik C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D. Immune Cells Mimic Endothelial Progenitor Colonies. Blood. 108: 1811-1811. DOI: 10.1182/Blood.V108.11.1811.1811 |
0.435 |
|
| Show low-probability matches. |